US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Biocryst Pharmaceuticals

9.70

-0.1200-1.22%

Post-market: 9.62-0.0800-0.82%19:57 EDT

Volume:2.76M

Turnover:26.56M

Market Cap:2.48B

PE:-6.44

High:9.72

Open:9.72

Low:9.46

Close:9.82

52wk High:11.22

52wk Low:6.00

Shares:255.54M

Float Shares:222.00M

Volume Ratio:1.21

T/O Rate:1.24%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.5054

EPS(LYR):1.21

ROE:587.33%

ROA:52.86%

PB:-5.46

PE(LYR):8.02

Loading ...

Overview Company News Filings

BioCryst to Discontinue Internal Discovery Programs, Close Birmingham Facility by Year-End

MT Newswires Live

Biocryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility

THOMSON REUTERS

Biocryst Pharmaceuticals - Reaffirms Full Year 2026 Orladeyo and Total Company Revenue Guidance

THOMSON REUTERS

Biocryst Pharmaceuticals - Shifts Strategic Focus to External Innovation for Rare Disease Pipeline

THOMSON REUTERS

Biocryst Pharmaceuticals - to Make Orladeyo Oral Pellets Available in Early August 2026

THOMSON REUTERS

Biocryst Pharmaceuticals - to Close Birmingham Discovery Center and End Internal Discovery Programs by End 2026

THOMSON REUTERS

Biocryst Pharmaceuticals - Completes Enrollment in Phase 3 Alpha-orbit Study for Navenibart

THOMSON REUTERS

Biocryst Pharmaceuticals - Improves 2026 Non-gaap Operating Expense Guidance to $420-$440 Mln

THOMSON REUTERS

Biocryst Pharmaceuticals Inc Fy2026 REV View $667.5 Mln

THOMSON REUTERS

How Investors Are Reacting To BioCryst (BCRX) Expanding Its HAE Prophylaxis Data Across Patient Groups

Simply Wall St.

BioCryst shareholders approve amended stock incentive plan, add 7 million shares

BioCryst Pharmaceuticals' New Clinical Data Demonstrated Reduced Hereditary Angioedema Attacks With Orladeyo Treatment

MT Newswires Live

BioCryst says post hoc ALPHA-STAR analysis shows navenibart cuts HAE attack rates across patient subgroups

BioCryst Presents New Clinical Data and Real-World Evidence Demonstrating Impact of Hae Portfolio at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting

THOMSON REUTERS

BioCryst grants 9 new hires options for 33,950 shares, RSUs for 80,650 shares under inducement plan

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

BioCryst presents new ORLADEYO, navenibart hereditary angioedema trial data at EAACI 2026

BioCryst director Amy E. McKee sells 11,180 shares worth $100,284.6

BioCryst Chief Legal Officer Alane P. Barnes sells 62,500 shares for $596,250

These Analysts Revise Their Forecasts On BioCryst Pharma After Q1 Earnings

Benzinga Earnings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BCRX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BCRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCRX\",,,,,undefined,":{"symbol":"BCRX","market":"US","secType":"STK","nameCN":"Biocryst Pharmaceuticals","latestPrice":9.7,"timestamp":1788206400000,"preClose":9.82,"halted":0,"volume":2756233,"hourTrading":{"tag":"盘后","latestPrice":9.62,"preClose":9.7,"latestTime":"19:57 EDT","volume":215637,"amount":2091768.541455,"timestamp":1788220679585,"change":-0.08,"changeRate":-0.008247,"amplitude":0.008247},"delay":0,"changeRate":-0.012219959266802544,"floatShares":222000000,"shares":255535105,"eps":-1.5053626,"marketStatus":"Closed","change":-0.12,"latestTime":"08-31 16:00:00 EDT","open":9.72,"high":9.72,"low":9.46,"amount":26563057.725849997,"amplitude":0.026477,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.5053626,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":762670800000,"exchange":"NASDAQ","adjPreClose":9.82,"preHourTrading":{"tag":"盘前","latestPrice":9.71,"preClose":9.82,"latestTime":"09:27 EDT","volume":1060,"amount":10329.164700000001,"timestamp":1788182873989,"change":-0.11,"changeRate":-0.011202,"amplitude":0.036558},"postHourTrading":{"tag":"盘后","latestPrice":9.62,"preClose":9.7,"latestTime":"19:57 EDT","volume":215637,"amount":2091768.541455,"timestamp":1788220679585,"change":-0.08,"changeRate":-0.008247,"amplitude":0.008247},"volumeRatio":1.21055,"impliedVol":0.6313,"impliedVolPercentile":0.502},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCRX\",,,,,undefined,":{"symbol":"BCRX","floatShares":222000000,"roa":"52.86%","roe":"587.33%","lyrEps":1.21,"volumeRatio":1.21055,"shares":255535105,"dividePrice":0,"high":9.72,"amplitude":0.026477,"preClose":9.82,"low":9.46,"week52Low":6,"pbRate":"-5.46","psRate":"2.64","week52High":11.22,"institutionHeld":0.9,"latestPrice":9.7,"eps":-1.5053626,"divideRate":0,"volume":2756233,"delay":0,"ttmEps":-1.5053626,"open":9.72,"prevYearClose":7.8,"prevWeekClose":9.82,"prevMonthClose":8.98,"prevQuarterClose":10,"fiveDayClose":9.68,"twentyDayClose":8.81,"sixtyDayClose":8.47},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"BCRX","fiscalQuarterEnding":"2026/06","expectedEps":0.14,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"pre","actualEps":0.3},{"market":"US","date":"2026-05-06","symbol":"BCRX","fiscalQuarterEnding":"2026/03","expectedEps":0.06,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"pre","actualEps":-0.03},{"market":"US","date":"2026-02-26","symbol":"BCRX","fiscalQuarterEnding":"2025/12","expectedEps":0.07,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":1.12},{"date":"2026-01-12","symbol":"BCRX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1768208400000,"name":null,"time":"Pre-MKt","dateTimestamp":1768194000000,"actualEps":null},{"market":"US","date":"2025-11-03","symbol":"BCRX","fiscalQuarterEnding":"2025/09","expectedEps":0.07,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762146000000,"reportTimeType":"pre","actualEps":0.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.6364,"hold":0.0909,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6364,"analysts":11,"updateTime":1784001600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BCRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BCRX","date":"2026-08-28","current":-6.367237,"percent":0.666124,"low":-214.840749,"twenty":-17.279915,"median":-10.618405,"eighty":-5.405319,"high":9.400473,"avg":-22.671472,"sd":42.03339,"marketCap":2522131486},"quantilePoints":[{"date":"2021-09-03","current":-13.083764,"twenty":-11.272485,"median":-8.334355,"eighty":-5.206578,"marketCap":2801103072},{"date":"2021-09-10","current":-12.699439,"twenty":-11.290353,"median":-8.334355,"eighty":-5.206578,"marketCap":2718822905},{"date":"2021-09-17","current":-13.117184,"twenty":-11.324018,"median":-8.334355,"eighty":-5.206578,"marketCap":2808257869},{"date":"2021-09-24","current":-12.465502,"twenty":-11.369016,"median":-8.334355,"eighty":-5.206578,"marketCap":2668739325},{"date":"2021-10-01","current":-11.47127,"twenty":-11.405963,"median":-8.334355,"eighty":-5.206578,"marketCap":2455884111},{"date":"2021-10-08","current":-12.081177,"twenty":-11.447508,"median":-8.334355,"eighty":-5.206578,"marketCap":2586459158},{"date":"2021-10-15","current":-12.640955,"twenty":-11.477201,"median":-8.334355,"eighty":-5.206578,"marketCap":2706302010},{"date":"2021-10-22","current":-12.281694,"twenty":-11.564062,"median":-8.334355,"eighty":-5.206578,"marketCap":2629387941},{"date":"2021-10-29","current":-12.473857,"twenty":-11.671007,"median":-8.334355,"eighty":-5.206578,"marketCap":2670528025},{"date":"2021-11-05","current":-9.846756,"twenty":-11.693218,"median":-8.334355,"eighty":-5.206578,"marketCap":2233007882},{"date":"2021-11-12","current":-9.719803,"twenty":-11.693218,"median":-8.334355,"eighty":-5.206578,"marketCap":2204218094},{"date":"2021-11-19","current":-9.43416,"twenty":-11.671007,"median":-8.334355,"eighty":-5.206578,"marketCap":2139441073},{"date":"2021-11-26","current":-9.902297,"twenty":-11.566663,"median":-8.334355,"eighty":-5.206578,"marketCap":2245603414},{"date":"2021-12-03","current":-9.077106,"twenty":-11.566663,"median":-8.334355,"eighty":-5.206578,"marketCap":2058469796},{"date":"2021-12-10","current":-9.243731,"twenty":-11.566663,"median":-8.334355,"eighty":-5.206578,"marketCap":2096256392},{"date":"2021-12-17","current":-10.338697,"twenty":-11.547357,"median":-8.334355,"eighty":-5.206578,"marketCap":2344568308},{"date":"2021-12-23","current":-11.04487,"twenty":-11.472736,"median":-8.334355,"eighty":-5.206578,"marketCap":2504711500},{"date":"2021-12-31","current":-10.989329,"twenty":-11.41685,"median":-8.334355,"eighty":-5.206578,"marketCap":2492115968},{"date":"2022-01-07","current":-9.17232,"twenty":-11.336787,"median":-8.340324,"eighty":-5.208094,"marketCap":2080062136},{"date":"2022-01-14","current":-12.282657,"twenty":-11.336787,"median":-8.340324,"eighty":-5.208094,"marketCap":2785411927},{"date":"2022-01-21","current":-10.933787,"twenty":-11.304581,"median":-8.340324,"eighty":-5.208094,"marketCap":2479520436},{"date":"2022-01-28","current":-11.798651,"twenty":-11.300042,"median":-8.340324,"eighty":-5.208094,"marketCap":2675650862},{"date":"2022-02-04","current":-12.068425,"twenty":-11.300042,"median":-8.340324,"eighty":-5.208094,"marketCap":2736829160},{"date":"2022-02-11","current":-14.115535,"twenty":-11.300042,"median":-8.340324,"eighty":-5.208094,"marketCap":3201064482},{"date":"2022-02-18","current":-14.869315,"twenty":-11.300042,"median":-8.340324,"eighty":-5.208094,"marketCap":3372003844},{"date":"2022-02-25","current":-17.086694,"twenty":-11.307904,"median":-8.340324,"eighty":-5.208094,"marketCap":3145011000},{"date":"2022-03-04","current":-16.152465,"twenty":-11.317818,"median":-8.340324,"eighty":-5.208094,"marketCap":2973054963},{"date":"2022-03-11","current":-16.17253,"twenty":-11.317818,"median":-8.340324,"eighty":-5.208094,"marketCap":2976748199},{"date":"2022-03-18","current":-16.272856,"twenty":-11.317818,"median":-8.340324,"eighty":-5.208094,"marketCap":2995214379},{"date":"2022-03-25","current":-16.042106,"twenty":-11.317818,"median":-8.340324,"eighty":-5.208094,"marketCap":2952742166},{"date":"2022-04-01","current":-16.644061,"twenty":-11.317818,"median":-8.340324,"eighty":-5.208094,"marketCap":3063539245},{"date":"2022-04-08","current":-11.156237,"twenty":-11.307904,"median":-8.340324,"eighty":-5.208094,"marketCap":2053439204},{"date":"2022-04-14","current":-11.4221,"twenty":-11.290289,"median":-8.340324,"eighty":-5.208094,"marketCap":2102374581},{"date":"2022-04-22","current":-9.701511,"twenty":-11.173318,"median":-8.340324,"eighty":-5.208094,"marketCap":1785679596},{"date":"2022-04-29","current":-9.366496,"twenty":-11.102733,"median":-8.340324,"eighty":-5.208094,"marketCap":1724015904},{"date":"2022-05-06","current":-8.696528,"twenty":-11.021077,"median":-8.340324,"eighty":-5.208094,"marketCap":1686900384},{"date":"2022-05-13","current":-8.027101,"twenty":-11.021077,"median":-8.301129,"eighty":-5.208094,"marketCap":1557048887},{"date":"2022-05-20","current":-8.706391,"twenty":-11.021077,"median":-8.282296,"eighty":-5.208094,"marketCap":1688813453},{"date":"2022-05-27","current":-9.337843,"twenty":-11.021077,"median":-8.294118,"eighty":-5.208094,"marketCap":1811298824},{"date":"2022-06-03","current":-9.997998,"twenty":-11.021077,"median":-8.301129,"eighty":-5.208094,"marketCap":1939351713},{"date":"2022-06-10","current":-9.433518,"twenty":-11.021077,"median":-8.301129,"eighty":-5.208094,"marketCap":1829857214},{"date":"2022-06-17","current":-9.203899,"twenty":-11.021077,"median":-8.301129,"eighty":-5.208094,"marketCap":1785317079},{"date":"2022-06-24","current":-10.29459,"twenty":-11.0226,"median":-8.297309,"eighty":-5.206578,"marketCap":1996882720},{"date":"2022-07-01","current":-10.371129,"twenty":-11.0226,"median":-8.297309,"eighty":-5.206578,"marketCap":2011729432},{"date":"2022-07-08","current":-11.557495,"twenty":-11.05766,"median":-8.297309,"eighty":-5.206578,"marketCap":2241853463},{"date":"2022-07-15","current":-11.146094,"twenty":-11.094816,"median":-8.297309,"eighty":-5.206578,"marketCap":2162052388},{"date":"2022-07-22","current":-10.629451,"twenty":-11.135446,"median":-8.297309,"eighty":-5.206578,"marketCap":2061837084},{"date":"2022-07-29","current":-10.543344,"twenty":-11.135446,"median":-8.334355,"eighty":-5.206578,"marketCap":2045134533},{"date":"2022-08-05","current":-12.462268,"twenty":-11.150151,"median":-8.374928,"eighty":-5.206578,"marketCap":2612527474},{"date":"2022-08-12","current":-12.985594,"twenty":-11.22776,"median":-8.407601,"eighty":-5.296059,"marketCap":2722235034},{"date":"2022-08-19","current":-12.533227,"twenty":-11.309589,"median":-8.455336,"eighty":-5.414226,"marketCap":2627403076},{"date":"2022-08-26","current":-12.648536,"twenty":-11.405675,"median":-8.531039,"eighty":-5.512419,"marketCap":2651575928},{"date":"2022-09-02","current":-12.480008,"twenty":-11.459768,"median":-8.596328,"eighty":-5.512419,"marketCap":2616246375},{"date":"2022-09-09","current":-11.930071,"twenty":-11.491893,"median":-8.652683,"eighty":-5.514453,"marketCap":2500960465},{"date":"2022-09-16","current":-11.663973,"twenty":-11.547357,"median":-8.701649,"eighty":-5.514453,"marketCap":2445176960},{"date":"2022-09-23","current":-10.963248,"twenty":-11.566478,"median":-8.729414,"eighty":-5.514453,"marketCap":2298280397},{"date":"2022-09-30","current":-11.176126,"twenty":-11.566478,"median":-8.857482,"eighty":-5.514453,"marketCap":2342907201},{"date":"2022-10-07","current":-12.11634,"twenty":-11.645286,"median":-8.89774,"eighty":-5.514453,"marketCap":2540008918},{"date":"2022-10-14","current":-12.001031,"twenty":-11.717338,"median":-8.933652,"eighty":-5.514453,"marketCap":2515836066},{"date":"2022-10-21","current":-12.542097,"twenty":-11.764614,"median":-9.020394,"eighty":-5.514453,"marketCap":2629262526},{"date":"2022-10-28","current":-12.453398,"twenty":-11.858323,"median":-9.042565,"eighty":-5.514453,"marketCap":2610668024},{"date":"2022-11-04","current":-11.994127,"twenty":-11.860318,"median":-9.07511,"eighty":-5.514453,"marketCap":2319112507},{"date":"2022-11-11","current":-12.697963,"twenty":-11.880929,"median":-9.17232,"eighty":-5.514453,"marketCap":2455201906},{"date":"2022-11-18","current":-11.984486,"twenty":-11.950615,"median":-9.209248,"eighty":-5.514453,"marketCap":2317248269},{"date":"2022-11-25","current":-11.839862,"twenty":-11.968356,"median":-9.243731,"eighty":-5.514453,"marketCap":2289284693},{"date":"2022-12-02","current":-12.331583,"twenty":-11.996889,"median":-9.311375,"eighty":-5.514453,"marketCap":2384360849},{"date":"2022-12-09","current":-10.123661,"twenty":-11.996889,"median":-9.356661,"eighty":-5.514453,"marketCap":1957450267},{"date":"2022-12-16","current":-10.54789,"twenty":-11.996889,"median":-9.390672,"eighty":-5.514453,"marketCap":2039476754},{"date":"2022-12-23","current":-11.039611,"twenty":-11.996889,"median":-9.418291,"eighty":-5.514453,"marketCap":2134552910},{"date":"2022-12-30","current":-11.068536,"twenty":-11.996889,"median":-9.433518,"eighty":-5.514453,"marketCap":2140145625},{"date":"2023-01-06","current":-11.396349,"twenty":-11.996889,"median":-9.433518,"eighty":-5.514453,"marketCap":2203529729},{"date":"2023-01-13","current":-9.795847,"twenty":-11.996889,"median":-9.433518,"eighty":-5.514453,"marketCap":1894066163},{"date":"2023-01-20","current":-10.027245,"twenty":-11.996889,"median":-9.433518,"eighty":-5.514453,"marketCap":1938807884},{"date":"2023-01-27","current":-10.200793,"twenty":-11.996889,"median":-9.44347,"eighty":-5.514453,"marketCap":1972364174},{"date":"2023-02-03","current":-10.171868,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1966771459},{"date":"2023-02-10","current":-9.940471,"twenty":-11.996889,"median":-9.477022,"eighty":-5.514453,"marketCap":1922029738},{"date":"2023-02-17","current":-9.834413,"twenty":-11.996889,"median":-9.500944,"eighty":-5.514453,"marketCap":1901523117},{"date":"2023-02-24","current":-6.919603,"twenty":-11.996889,"median":-9.471788,"eighty":-5.514453,"marketCap":1709944600},{"date":"2023-03-03","current":-6.703271,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1656485494},{"date":"2023-03-10","current":-6.32197,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1562259925},{"date":"2023-03-17","current":-6.177076,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1526454209},{"date":"2023-03-24","current":-6.482116,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1601834664},{"date":"2023-03-31","current":-6.3601,"twenty":-11.995508,"median":-9.460929,"eighty":-5.517486,"marketCap":1571682482},{"date":"2023-04-06","current":-6.504994,"twenty":-11.995508,"median":-9.460929,"eighty":-5.517486,"marketCap":1607488198},{"date":"2023-04-14","current":-6.413482,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1584874062},{"date":"2023-04-21","current":-5.628002,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1390769391},{"date":"2023-04-28","current":-5.756703,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1422573360},{"date":"2023-05-05","current":-7.072432,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1600158879},{"date":"2023-05-12","current":-6.980582,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1579377595},{"date":"2023-05-19","current":-6.989451,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1581384167},{"date":"2023-05-26","current":-6.672128,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1509588948},{"date":"2023-06-02","current":-7.006152,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1585162862},{"date":"2023-06-09","current":-7.356877,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1664515473},{"date":"2023-06-16","current":-6.663777,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1507699600},{"date":"2023-06-23","current":-5.845419,"twenty":-11.998269,"median":-9.468843,"eighty":-5.511419,"marketCap":1322543509},{"date":"2023-06-30","current":-5.812016,"twenty":-11.99965,"median":-9.471788,"eighty":-5.508386,"marketCap":1314986117},{"date":"2023-07-07","current":-5.812016,"twenty":-11.99965,"median":-9.471788,"eighty":-5.508386,"marketCap":1314986117},{"date":"2023-07-14","current":-6.13769,"twenty":-11.99965,"median":-9.471788,"eighty":-5.508386,"marketCap":1388670684},{"date":"2023-07-21","current":-5.987379,"twenty":-11.99965,"median":-9.471788,"eighty":-5.508386,"marketCap":1354662422},{"date":"2023-07-28","current":-6.471714,"twenty":-11.99965,"median":-9.471788,"eighty":-5.508386,"marketCap":1464244599},{"date":"2023-08-04","current":-5.527341,"twenty":-11.99965,"median":-9.471788,"eighty":-5.487548,"marketCap":1341596280},{"date":"2023-08-11","current":-5.519614,"twenty":-11.99965,"median":-9.45596,"eighty":-5.447182,"marketCap":1339720706},{"date":"2023-08-18","current":-5.464964,"twenty":-11.99965,"median":-9.433518,"eighty":-5.42126,"marketCap":1326456145},{"date":"2023-08-25","current":-5.652335,"twenty":-11.99965,"median":-9.412435,"eighty":-5.42126,"marketCap":1371934641},{"date":"2023-09-01","current":-5.550842,"twenty":-11.99965,"median":-9.381701,"eighty":-5.418337,"marketCap":1347300455},{"date":"2023-09-08","current":-5.347858,"twenty":-11.99965,"median":-9.34688,"eighty":-5.418122,"marketCap":1298032084},{"date":"2023-09-15","current":-5.402508,"twenty":-11.99965,"median":-9.253895,"eighty":-5.403361,"marketCap":1311296646},{"date":"2023-09-22","current":-5.589878,"twenty":-11.99965,"median":-9.209248,"eighty":-5.402508,"marketCap":1356775142},{"date":"2023-09-29","current":-5.652335,"twenty":-11.99965,"median":-9.17232,"eighty":-5.402508,"marketCap":1371934641},{"date":"2023-10-06","current":-5.176102,"twenty":-11.99965,"median":-9.07511,"eighty":-5.347858,"marketCap":1256343463},{"date":"2023-10-13","current":-4.668641,"twenty":-11.99965,"median":-9.042565,"eighty":-5.279367,"marketCap":1133172535},{"date":"2023-10-20","current":-4.465657,"twenty":-11.99965,"median":-8.948564,"eighty":-5.203545,"marketCap":1083904164},{"date":"2023-10-27","current":-4.262672,"twenty":-12.001031,"median":-8.93448,"eighty":-5.139124,"marketCap":1034635793},{"date":"2023-11-03","current":-4.529272,"twenty":-12.001031,"median":-8.88682,"eighty":-5.005907,"marketCap":1070488920},{"date":"2023-11-10","current":-4.34144,"twenty":-12.001031,"median":-8.834028,"eighty":-4.882775,"marketCap":1026094993},{"date":"2023-11-17","current":-4.454092,"twenty":-12.001031,"median":-8.801384,"eighty":-4.760324,"marketCap":1052720213},{"date":"2023-11-24","current":-4.783383,"twenty":-12.001031,"median":-8.70402,"eighty":-4.675094,"marketCap":1130547777},{"date":"2023-12-01","current":-5.095343,"twenty":-12.001031,"median":-8.655618,"eighty":-4.65615,"marketCap":1204279154},{"date":"2023-12-08","current":-4.913366,"twenty":-12.001031,"median":-8.596328,"eighty":-4.662395,"marketCap":1161269184},{"date":"2023-12-15","current":-5.571948,"twenty":-12.001031,"median":-8.515042,"eighty":-4.662395,"marketCap":1316924313},{"date":"2023-12-22","current":-4.991356,"twenty":-12.001031,"median":-8.442474,"eighty":-4.662395,"marketCap":1179702028},{"date":"2023-12-29","current":-5.277319,"twenty":-12.001031,"median":-8.374928,"eighty":-4.65615,"marketCap":1247289124},{"date":"2024-01-05","current":-5.597945,"twenty":-12.001031,"median":-8.31341,"eighty":-4.649904,"marketCap":1323068594},{"date":"2024-01-12","current":-5.60661,"twenty":-12.001031,"median":-8.201319,"eighty":-4.649904,"marketCap":1325116688},{"date":"2024-01-19","current":-4.991356,"twenty":-12.001031,"median":-8.150833,"eighty":-4.643659,"marketCap":1179702028},{"date":"2024-01-26","current":-4.722724,"twenty":-12.001031,"median":-8.091771,"eighty":-4.649904,"marketCap":1116211121},{"date":"2024-02-02","current":-4.57541,"twenty":-12.001031,"median":-7.991699,"eighty":-4.636607,"marketCap":1081393526},{"date":"2024-02-09","current":-4.610072,"twenty":-12.001031,"median":-7.838887,"eighty":-4.610072,"marketCap":1089585901},{"date":"2024-02-16","current":-4.88737,"twenty":-12.001031,"median":-7.609687,"eighty":-4.610072,"marketCap":1155124903},{"date":"2024-02-23","current":-5.043349,"twenty":-12.001031,"median":-7.563845,"eighty":-4.610072,"marketCap":1191990591},{"date":"2024-03-01","current":-5.123286,"twenty":-12.001031,"median":-7.435334,"eighty":-4.610072,"marketCap":1160624100},{"date":"2024-03-08","current":-4.713787,"twenty":-12.001031,"median":-7.353397,"eighty":-4.610072,"marketCap":1067856632},{"date":"2024-03-15","current":-4.449888,"twenty":-12.001031,"median":-7.26889,"eighty":-4.603663,"marketCap":1008073152},{"date":"2024-03-22","current":-4.995886,"twenty":-12.001031,"median":-7.213664,"eighty":-4.593526,"marketCap":1131763110},{"date":"2024-03-28","current":-4.686487,"twenty":-12.001031,"median":-7.152558,"eighty":-4.584506,"marketCap":1061672134},{"date":"2024-04-05","current":-4.185989,"twenty":-12.001031,"median":-7.089132,"eighty":-4.565435,"marketCap":948289673},{"date":"2024-04-12","current":-4.640987,"twenty":-12.001031,"median":-7.047905,"eighty":-4.535634,"marketCap":1051364637},{"date":"2024-04-19","current":-4.094989,"twenty":-12.001031,"median":-6.983186,"eighty":-4.459327,"marketCap":927674680},{"date":"2024-04-26","current":-3.788907,"twenty":-12.001031,"median":-6.960486,"eighty":-4.426785,"marketCap":858335308},{"date":"2024-05-03","current":-4.080362,"twenty":-12.001031,"median":-6.912774,"eighty":-4.341139,"marketCap":924361101},{"date":"2024-05-10","current":-5.283475,"twenty":-12.001031,"median":-6.87327,"eighty":-4.341139,"marketCap":1102053649},{"date":"2024-05-17","current":-6.401514,"twenty":-12.001031,"median":-6.822696,"eighty":-4.341139,"marketCap":1335259759},{"date":"2024-05-24","current":-6.262996,"twenty":-12.001031,"median":-6.79385,"eighty":-4.398243,"marketCap":1306366967},{"date":"2024-05-31","current":-6.500455,"twenty":-12.001031,"median":-6.79385,"eighty":-4.442608,"marketCap":1355897468},{"date":"2024-06-07","current":-6.371831,"twenty":-12.001031,"median":-6.79385,"eighty":-4.464497,"marketCap":1329068446},{"date":"2024-06-14","current":-6.164054,"twenty":-12.001031,"median":-6.79982,"eighty":-4.547101,"marketCap":1285729258},{"date":"2024-06-21","current":-6.084901,"twenty":-12.001031,"median":-6.807212,"eighty":-4.575047,"marketCap":1269219091},{"date":"2024-06-28","current":-6.045324,"twenty":-12.003012,"median":-6.830789,"eighty":-4.593526,"marketCap":1260964007},{"date":"2024-07-05","current":-6.342149,"twenty":-12.003012,"median":-6.830789,"eighty":-4.610072,"marketCap":1322877134},{"date":"2024-07-12","current":-6.96548,"twenty":-12.003012,"median":-6.839984,"eighty":-4.630756,"marketCap":1452894699},{"date":"2024-07-15","current":-7.074316,"twenty":-12.003012,"median":-6.860942,"eighty":-4.636875,"marketCap":1475596179},{"date":"2024-08-02","current":-7.034739,"twenty":-12.01194,"median":-6.912774,"eighty":-4.705393,"marketCap":1467341095},{"date":"2024-08-09","current":-11.29889,"twenty":-12.01194,"median":-6.946957,"eighty":-4.741087,"marketCap":1648880909},{"date":"2024-08-16","current":-10.81688,"twenty":-12.01194,"median":-6.980841,"eighty":-4.774717,"marketCap":1578539691},{"date":"2024-08-23","current":-11.242183,"twenty":-12.01194,"median":-7.018642,"eighty":-4.826711,"marketCap":1640605472},{"date":"2024-08-30","current":-12.234557,"twenty":-12.014338,"median":-7.070457,"eighty":-4.877587,"marketCap":1785425627},{"date":"2024-09-06","current":-11.525718,"twenty":-12.035026,"median":-7.101921,"eighty":-4.88737,"marketCap":1681982659},{"date":"2024-09-13","current":-10.987001,"twenty":-12.035026,"median":-7.152558,"eighty":-4.913366,"marketCap":1603366004},{"date":"2024-09-20","current":-11.554072,"twenty":-12.035026,"median":-7.224485,"eighty":-4.977686,"marketCap":1686120378},{"date":"2024-09-27","current":-10.745996,"twenty":-12.035026,"median":-7.281714,"eighty":-4.996539,"marketCap":1568195394},{"date":"2024-10-04","current":-10.519167,"twenty":-12.035026,"median":-7.356877,"eighty":-5.042892,"marketCap":1535093645},{"date":"2024-10-11","current":-10.093864,"twenty":-12.035026,"median":-7.468832,"eighty":-5.095343,"marketCap":1473027864},{"date":"2024-10-18","current":-10.618405,"twenty":-12.035026,"median":-7.580205,"eighty":-5.147336,"marketCap":1549575660},{"date":"2024-10-25","current":-11.596602,"twenty":-12.035026,"median":-7.766312,"eighty":-5.164667,"marketCap":1692326956},{"date":"2024-10-31","current":-11.865961,"twenty":-12.035026,"median":-8.017533,"eighty":-5.202028,"marketCap":1731635284},{"date":"2024-11-08","current":-12.831088,"twenty":-12.05083,"median":-8.266748,"eighty":-5.240678,"marketCap":1588706819},{"date":"2024-11-15","current":-12.463052,"twenty":-12.117301,"median":-8.515042,"eighty":-5.262947,"marketCap":1543137653},{"date":"2024-11-22","current":-12.529967,"twenty":-12.127993,"median":-8.696528,"eighty":-5.277751,"marketCap":1551422956},{"date":"2024-11-29","current":-12.546696,"twenty":-12.162273,"median":-8.89774,"eighty":-5.307206,"marketCap":1553494282},{"date":"2024-12-06","current":-13.11548,"twenty":-12.179299,"median":-9.041252,"eighty":-5.338414,"marketCap":1623919356},{"date":"2024-12-13","current":-12.713985,"twenty":-12.207624,"median":-9.17232,"eighty":-5.363975,"marketCap":1574207539},{"date":"2024-12-20","current":-12.362678,"twenty":-12.232231,"median":-9.243731,"eighty":-5.409294,"marketCap":1530709699},{"date":"2024-12-27","current":-12.914733,"twenty":-12.259544,"median":-9.356661,"eighty":-5.41898,"marketCap":1599063448},{"date":"2025-01-03","current":-13.098751,"twenty":-12.26852,"median":-9.418291,"eighty":-5.454663,"marketCap":1621848030},{"date":"2025-01-10","current":-13.466787,"twenty":-12.292012,"median":-9.454684,"eighty":-5.48209,"marketCap":1667417196},{"date":"2025-01-17","current":-11.810623,"twenty":-12.304269,"median":-9.573636,"eighty":-5.520157,"marketCap":1462355951},{"date":"2025-01-24","current":-12.931462,"twenty":-12.325269,"median":-9.656044,"eighty":-5.52783,"marketCap":1601134773},{"date":"2025-01-31","current":-13.165667,"twenty":-12.367034,"median":-9.698399,"eighty":-5.550842,"marketCap":1630133333},{"date":"2025-02-07","current":-14.604354,"twenty":-12.442894,"median":-9.725843,"eighty":-5.566615,"marketCap":1808267344},{"date":"2025-02-14","current":-14.754915,"twenty":-12.465502,"median":-9.795847,"eighty":-5.593158,"marketCap":1826909276},{"date":"2025-02-21","current":-15.708464,"twenty":-12.479871,"median":-9.828959,"eighty":-5.626683,"marketCap":1944974841},{"date":"2025-02-28","current":-19.913045,"twenty":-12.502,"median":-9.865139,"eighty":-5.652335,"marketCap":1769891369},{"date":"2025-03-07","current":-18.47893,"twenty":-12.529967,"median":-9.901904,"eighty":-5.678879,"marketCap":1642425757},{"date":"2025-03-14","current":-17.726607,"twenty":-12.546696,"median":-9.940471,"eighty":-5.714205,"marketCap":1575558550},{"date":"2025-03-21","current":-18.079258,"twenty":-12.59352,"median":-9.969395,"eighty":-5.738213,"marketCap":1606902553},{"date":"2025-03-28","current":-18.4084,"twenty":-12.615114,"median":-10.036268,"eighty":-5.765731,"marketCap":1636156956},{"date":"2025-04-04","current":-17.232895,"twenty":-12.640439,"median":-10.100661,"eighty":-5.812016,"marketCap":1531676946},{"date":"2025-04-11","current":-15.069967,"twenty":-12.698553,"median":-10.126993,"eighty":-5.822454,"marketCap":1339433728},{"date":"2025-04-17","current":-16.974284,"twenty":-12.71197,"median":-10.145498,"eighty":-5.831428,"marketCap":1508691344},{"date":"2025-04-25","current":-19.325293,"twenty":-12.737872,"median":-10.203083,"eighty":-5.866249,"marketCap":1717651364},{"date":"2025-05-02","current":-20.501581,"twenty":-12.762442,"median":-10.249001,"eighty":-5.885575,"marketCap":1822201052},{"date":"2025-05-09","current":-38.821072,"twenty":-12.806107,"median":-10.263824,"eighty":-5.902709,"marketCap":2075762718},{"date":"2025-05-16","current":-39.955962,"twenty":-12.825479,"median":-10.297115,"eighty":-5.902709,"marketCap":2136445297},{"date":"2025-05-23","current":-40.660377,"twenty":-12.846485,"median":-10.335775,"eighty":-5.902709,"marketCap":2174110346},{"date":"2025-05-30","current":-42.57795,"twenty":-12.857594,"median":-10.355059,"eighty":-5.902709,"marketCap":2276642981},{"date":"2025-06-06","current":-42.969291,"twenty":-12.908311,"median":-10.399955,"eighty":-5.902709,"marketCap":2297568008},{"date":"2025-06-13","current":-40.699511,"twenty":-12.928886,"median":-10.422124,"eighty":-5.902709,"marketCap":2176202849},{"date":"2025-06-20","current":-38.977609,"twenty":-12.94006,"median":-10.437012,"eighty":-5.901193,"marketCap":2084132729},{"date":"2025-06-27","current":-37.803584,"twenty":-12.994531,"median":-10.509424,"eighty":-5.901193,"marketCap":2021357646},{"date":"2025-07-03","current":-34.985926,"twenty":-13.015253,"median":-10.530976,"eighty":-5.901193,"marketCap":1870697449},{"date":"2025-07-11","current":-34.751121,"twenty":-13.083416,"median":-10.547705,"eighty":-5.901193,"marketCap":1858142433},{"date":"2025-07-18","current":-34.046706,"twenty":-13.098751,"median":-10.601323,"eighty":-5.901193,"marketCap":1820477383},{"date":"2025-07-25","current":-33.459694,"twenty":-13.132835,"median":-10.623928,"eighty":-5.901193,"marketCap":1789089842},{"date":"2025-08-01","current":-31.855194,"twenty":-13.205816,"median":-10.65337,"eighty":-5.901193,"marketCap":1703297230},{"date":"2025-08-08","current":-49.080304,"twenty":-13.242261,"median":-10.686123,"eighty":-5.901193,"marketCap":1752706750},{"date":"2025-08-15","current":-49.671744,"twenty":-13.26604,"median":-10.723698,"eighty":-5.901193,"marketCap":1773827633},{"date":"2025-08-22","current":-49.260262,"twenty":-13.401187,"median":-10.745996,"eighty":-5.901193,"marketCap":1759133203},{"date":"2025-08-29","current":-49.78931,"twenty":-13.465608,"median":-10.774079,"eighty":-5.901193,"marketCap":1778026042},{"date":"2025-09-05","current":-48.613647,"twenty":-13.493154,"median":-10.802703,"eighty":-5.930008,"marketCap":1736041956},{"date":"2025-09-12","current":-47.437985,"twenty":-13.600619,"median":-10.820878,"eighty":-5.95556,"marketCap":1694057870},{"date":"2025-09-19","current":-46.79137,"twenty":-13.669547,"median":-10.866357,"eighty":-5.95556,"marketCap":1670966622},{"date":"2025-09-26","current":-44.969093,"twenty":-13.789991,"median":-10.903154,"eighty":-5.987379,"marketCap":1605891289},{"date":"2025-10-03","current":-43.088033,"twenty":-13.833065,"median":-10.939826,"eighty":-6.004458,"marketCap":1538716751},{"date":"2025-10-10","current":-42.617768,"twenty":-13.963142,"median":-10.960947,"eighty":-6.056554,"marketCap":1521923117},{"date":"2025-10-17","current":-39.502262,"twenty":-14.085315,"median":-10.984198,"eighty":-6.088859,"marketCap":1410665289},{"date":"2025-10-24","current":-42.265069,"twenty":-14.180162,"median":-11.039611,"eighty":-6.12712,"marketCap":1509327891},{"date":"2025-10-31","current":-42.741438,"twenty":-14.263285,"median":-11.089358,"eighty":-6.154198,"marketCap":1526339476},{"date":"2025-11-07","current":-168.597661,"twenty":-14.417657,"median":-11.142945,"eighty":-6.171663,"marketCap":1480118864},{"date":"2025-11-14","current":-165.479923,"twenty":-14.55044,"median":-11.160063,"eighty":-6.196567,"marketCap":1452748245},{"date":"2025-11-21","current":-168.597661,"twenty":-14.62077,"median":-11.194519,"eighty":-6.230458,"marketCap":1480118864},{"date":"2025-11-28","current":-172.19505,"twenty":-14.698437,"median":-11.235095,"eighty":-6.231029,"marketCap":1511700348},{"date":"2025-12-05","current":-187.783739,"twenty":-14.878402,"median":-11.277624,"eighty":-6.231029,"marketCap":1648553443},{"date":"2025-12-12","current":-181.788089,"twenty":-15.125737,"median":-11.305195,"eighty":-6.231029,"marketCap":1595917637},{"date":"2025-12-19","current":-174.833136,"twenty":-15.37832,"median":-11.305195,"eighty":-6.231029,"marketCap":1534860102},{"date":"2025-12-26","current":-184.666001,"twenty":-15.67732,"median":-11.316476,"eighty":-6.231029,"marketCap":1621182824},{"date":"2026-01-02","current":-187.064261,"twenty":-15.827811,"median":-11.354561,"eighty":-6.231029,"marketCap":1642237147},{"date":"2026-01-09","current":-182.747393,"twenty":-16.019775,"median":-11.403064,"eighty":-6.231029,"marketCap":1604339366},{"date":"2026-01-16","current":-171.955225,"twenty":-16.244764,"median":-11.414808,"eighty":-6.231029,"marketCap":1509594916},{"date":"2026-01-23","current":-161.882534,"twenty":-16.309157,"median":-11.414808,"eighty":-6.231029,"marketCap":1421166762},{"date":"2026-01-30","current":-188.303258,"twenty":-16.547622,"median":-11.414808,"eighty":-6.231029,"marketCap":1653114304},{"date":"2026-02-06","current":-176.163768,"twenty":-16.702785,"median":-11.414808,"eighty":-6.231029,"marketCap":1546541717},{"date":"2026-02-13","current":-191.973337,"twenty":-16.862772,"median":-11.414808,"eighty":-6.231029,"marketCap":1685333923},{"date":"2026-02-20","current":-211.17067,"twenty":-17.036898,"median":-11.414808,"eighty":-6.231029,"marketCap":1853867315},{"date":"2026-02-27","current":7.420428,"twenty":-17.232895,"median":-11.415632,"eighty":-6.230458,"marketCap":1957961469},{"date":"2026-03-06","current":8.079274,"twenty":-17.232895,"median":-11.405991,"eighty":-6.173948,"marketCap":2131805270},{"date":"2026-03-13","current":7.965213,"twenty":-17.232895,"median":-11.353525,"eighty":-6.154198,"marketCap":2101709195},{"date":"2026-03-20","current":9.324432,"twenty":-17.232895,"median":-11.313067,"eighty":-6.124478,"marketCap":2460354082},{"date":"2026-03-27","current":9.086807,"twenty":-17.232895,"median":-11.306219,"eighty":-6.084901,"marketCap":2397653927},{"date":"2026-04-02","current":8.915716,"twenty":-17.232895,"median":-11.306219,"eighty":-6.055059,"marketCap":2352509815},{"date":"2026-04-10","current":9.400473,"twenty":-17.232895,"median":-11.306219,"eighty":-5.987379,"marketCap":2480418131},{"date":"2026-04-17","current":9.048787,"twenty":-17.232895,"median":-11.306219,"eighty":-5.953976,"marketCap":2387621902},{"date":"2026-04-24","current":8.326405,"twenty":-17.232895,"median":-11.29889,"eighty":-5.887172,"marketCap":2197013431},{"date":"2026-05-01","current":8.821349,"twenty":-17.232895,"median":-11.264059,"eighty":-5.853769,"marketCap":2327609998},{"date":"2026-05-08","current":-4.939152,"twenty":-17.232895,"median":-11.264059,"eighty":-5.817863,"marketCap":2262047674},{"date":"2026-05-15","current":-5.310976,"twenty":-17.232895,"median":-11.264059,"eighty":-5.756703,"marketCap":2432336656},{"date":"2026-05-22","current":-4.645023,"twenty":-17.232895,"median":-11.203561,"eighty":-5.734766,"marketCap":2127341464},{"date":"2026-05-29","current":-5.050144,"twenty":-17.256405,"median":-11.160063,"eighty":-5.682002,"marketCap":2312880206},{"date":"2026-06-05","current":-4.700519,"twenty":-17.232895,"median":-11.142945,"eighty":-5.652335,"marketCap":2152757730},{"date":"2026-06-12","current":-4.717168,"twenty":-17.232895,"median":-11.086238,"eighty":-5.574264,"marketCap":2160382610},{"date":"2026-06-18","current":-4.9669,"twenty":-17.232895,"median":-11.039611,"eighty":-5.558649,"marketCap":2274755807},{"date":"2026-06-26","current":-5.494113,"twenty":-17.256405,"median":-10.977426,"eighty":-5.527421,"marketCap":2516210334},{"date":"2026-07-02","current":-5.355373,"twenty":-17.256405,"median":-10.960947,"eighty":-5.518953,"marketCap":2452669669},{"date":"2026-07-10","current":-5.949181,"twenty":-17.256405,"median":-10.92462,"eighty":-5.513849,"marketCap":2724623715},{"date":"2026-07-17","current":-5.052919,"twenty":-17.256405,"median":-10.849846,"eighty":-5.491406,"marketCap":2314151019},{"date":"2026-07-24","current":-5.205533,"twenty":-17.256405,"median":-10.809791,"eighty":-5.458868,"marketCap":2384045750},{"date":"2026-07-31","current":-5.127839,"twenty":-17.279915,"median":-10.769647,"eighty":-5.418122,"marketCap":2348462978},{"date":"2026-08-07","current":-6.177913,"twenty":-17.279915,"median":-10.74426,"eighty":-5.405319,"marketCap":2376476476},{"date":"2026-08-14","current":-6.516702,"twenty":-17.279915,"median":-10.703465,"eighty":-5.405319,"marketCap":2506799380},{"date":"2026-08-21","current":-6.417058,"twenty":-17.279915,"median":-10.648586,"eighty":-5.405319,"marketCap":2468469114},{"date":"2026-08-28","current":-6.55656,"twenty":-17.279915,"median":-10.618405,"eighty":-5.405319,"marketCap":2522131486}],"updateTime":1788195533854},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BCRX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2647797873","title":"BioCryst to Discontinue Internal Discovery Programs, Close Birmingham Facility by Year-End","url":"https://stock-news.laohu8.com/highlight/detail?id=2647797873","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647797873?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:06","pubTimestamp":1782734762,"startTime":"0","endTime":"0","summary":"BioCryst Pharmaceuticals (BCRX) said Monday it will discontinue its internal discovery programs and close its discovery center of excellence facility in Birmingham, Alabama, by the end of 2026 to prio","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4547","BCRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647759543","title":"Biocryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2647759543","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647759543?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:00","pubTimestamp":1782730825,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN43109Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4547","BCRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647759013","title":"Biocryst Pharmaceuticals - Reaffirms Full Year 2026 Orladeyo and Total Company Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2647759013","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647759013?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:00","pubTimestamp":1782730825,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN43109Q:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCRX","BK4547","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647537596","title":"Biocryst Pharmaceuticals - Shifts Strategic Focus to External Innovation for Rare Disease Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2647537596","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647537596?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:00","pubTimestamp":1782730825,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN43109Q:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCRX","BK4139","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647437519","title":"Biocryst Pharmaceuticals - to Make Orladeyo Oral Pellets Available in Early August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2647437519","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647437519?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:00","pubTimestamp":1782730825,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN43109Q:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCRX","BK4139","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647375996","title":"Biocryst Pharmaceuticals - to Close Birmingham Discovery Center and End Internal Discovery Programs by End 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2647375996","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647375996?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:00","pubTimestamp":1782730825,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN43109Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4547","BK4139","BCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647375937","title":"Biocryst Pharmaceuticals - Completes Enrollment in Phase 3 Alpha-orbit Study for Navenibart","url":"https://stock-news.laohu8.com/highlight/detail?id=2647375937","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647375937?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:00","pubTimestamp":1782730825,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN43109Q:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4547","BK4139","BCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647375906","title":"Biocryst Pharmaceuticals - Improves 2026 Non-gaap Operating Expense Guidance to $420-$440 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2647375906","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647375906?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:00","pubTimestamp":1782730825,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN43109Q:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4547","BCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647375235","title":"Biocryst Pharmaceuticals Inc Fy2026 REV View $667.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2647375235","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647375235?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:00","pubTimestamp":1782730825,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN43109Q:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4547","BCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643229941","title":"How Investors Are Reacting To BioCryst (BCRX) Expanding Its HAE Prophylaxis Data Across Patient Groups","url":"https://stock-news.laohu8.com/highlight/detail?id=2643229941","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643229941?lang=en_us&edition=fundamental","pubTime":"2026-06-15 10:12","pubTimestamp":1781489538,"startTime":"0","endTime":"0","summary":"Earlier this week, BioCryst Pharmaceuticals reported new clinical trial and real-world data for its oral HAE prophylaxis ORLADEYO and investigational antibody navenibart, presented across multiple posters at the EAACI 2026 meeting in Istanbul.\nThe breadth of data, with sustained pediatric outcomes for ORLADEYO and subgroup consistency for navenibart, highlights how BioCryst is trying to extend HAE prophylaxis across age ranges and patient profiles.\nNext, we’ll examine how these broader,...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bcrx/biocryst-pharmaceuticals/news/how-investors-are-reacting-to-biocryst-bcrx-expanding-its-ha","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bcrx/biocryst-pharmaceuticals/news/how-investors-are-reacting-to-biocryst-bcrx-expanding-its-ha","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BCRX","LU0205193047.USD","BK4198","LU0205194284.USD","LU1169589451.USD","IE0034390439.USD","LU1169590202.USD","LU0106261612.USD","HAE","IE00B64QTZ34.USD","BK4211","BK4139","BK4547","LU0012050646.USD","IE00BLDYK493.USD","IE00B19Z6F94.USD","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643218880","title":"BioCryst shareholders approve amended stock incentive plan, add 7 million shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2643218880","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643218880?lang=en_us&edition=fundamental","pubTime":"2026-06-13 04:11","pubTimestamp":1781295103,"startTime":"0","endTime":"0","summary":"BioCryst held its annual shareholder meeting on June 11, 2026.Shareholders ratified Ernst & Young as independent registered public accountants for 2026.Investors backed an amended and restated Stock Incentive Plan, expanding the share pool by 7 million shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCryst Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL1s4hfG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4547","BCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642260401","title":"BioCryst Pharmaceuticals' New Clinical Data Demonstrated Reduced Hereditary Angioedema Attacks With Orladeyo Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2642260401","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642260401?lang=en_us&edition=fundamental","pubTime":"2026-06-12 19:55","pubTimestamp":1781265347,"startTime":"0","endTime":"0","summary":"BioCryst Pharmaceuticals'  Orladeyo was associated with \"early and sustained reductions\" in hereditary angioedema or HAE attacks, demonstrated by new clinical data from the ongoing APeX-P study, the company said Friday.Updated analysis of 48-week data from the study showed that Orladeyo treatment reduced HAE attack rates that require on-demand treatment and attacks that require professional care, without significant safety concerns, BioCryst said. The study assessed patients aged 2 to less than 12 years old.BioCryst also reported new data from its phase 1b/2 study of navenibart in HAE, demonstrating reductions in overall HAE attack rate. The analysis supports the ongoing phase 3 trial of navenibart as a potential long-acting therapy for the broad HAE patient population, the company added.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4547","BCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642321267","title":"BioCryst says post hoc ALPHA-STAR analysis shows navenibart cuts HAE attack rates across patient subgroups","url":"https://stock-news.laohu8.com/highlight/detail?id=2642321267","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642321267?lang=en_us&edition=fundamental","pubTime":"2026-06-12 19:00","pubTimestamp":1781262059,"startTime":"0","endTime":"0","summary":"BioCryst disclosed new clinical data for ORLADEYO, with posters scheduled for presentation at the EAACI meeting in Istanbul on June 12-15.A long-term pediatric study showed sustained reductions in hereditary angioedema attacks needing rescue medication or professional care, with no new safety signals.A post hoc analysis of the early-stage ALPHA-STAR trial found investigational navenibart cut attack burden across patient subgroups, supporting its ongoing Phase 3 program.Separate real-world analyses set for EAACI pointed to fewer attacks, lower healthcare use, and strong patient satisfaction for ORLADEYO, including patients switching from other prophylaxis.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL4V9lCL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCRX","BK4585","LU2095319765.USD","BK4588","IE00B64PRP62.GBP","SG9999014005.SGD","NDAQ","SG9999014021.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","BK4547","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","SG9999014039.USD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","SG9999014013.SGD","BK4139","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642673302","title":"BioCryst Presents New Clinical Data and Real-World Evidence Demonstrating Impact of Hae Portfolio at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2642673302","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642673302?lang=en_us&edition=fundamental","pubTime":"2026-06-12 19:00","pubTimestamp":1781262021,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nFWN42K0DY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCRX","BK4139","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642492051","title":"BioCryst grants 9 new hires options for 33,950 shares, RSUs for 80,650 shares under inducement plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2642492051","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642492051?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:05","pubTimestamp":1781035522,"startTime":"0","endTime":"0","summary":"BioCryst Pharmaceuticals granted inducement equity awards to nine newly hired employees, covering 33,950 stock options and 80,650 RSUs.Options were struck at $8.57 per share, matching the June 1 closing price; each option carries a 10-year term.Awards vest in four equal annual installments starting on the first anniversary of the grant date, contingent on continued service.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL4GZWPR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","LU2210149790.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4112","LU2095319765.USD","BK4139","BK4585","NDAQ","LU2210150020.SGD","SG9999014021.USD","LU0314104364.USD","SG9999014005.SGD","IE00B64PRP62.GBP","BK4588","BCRX","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","SG9999014039.USD","IE00BN0W2T93.GBP","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642713492","title":"BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642713492","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642713492?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:05","pubTimestamp":1781035500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nTUAC8N8VQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4547","BCRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638041715","title":"BioCryst presents new ORLADEYO, navenibart hereditary angioedema trial data at EAACI 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2638041715","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638041715?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:03","pubTimestamp":1779879807,"startTime":"0","endTime":"0","summary":"BioCryst flagged new hereditary angioedema data for ORLADEYO and investigational navenibart at the EAACI meeting in Istanbul, June 12-15, 2026.Results will be presented in the future through seven abstracts spanning clinical-trial findings, real-world outcomes, and switching experience from other preventive therapies.ORLADEYO reports focus on fewer attacks, reduced need for rescue treatment or professional care, and lower healthcare resource use across adult, adolescent, and pediatric patients.Navenibart data from the ALPHA-STAR trial highlight clinical outcomes across patient subgroups, supporting its positioning as a long-acting preventive option.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL9GrLP5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","IE00BGHQF748.EUR","NDAQ","LU2210149790.SGD","IE00BKPKM429.USD","BK4139","LU2095319765.USD","SG9999014021.USD","SG9999014039.USD","SG9999014005.SGD","IE00B64PRP62.GBP","BK4112","SG9999014013.SGD","LU2210150020.SGD","BK4547","BK4585","BK4588","LU0314104364.USD","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","BCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636586103","title":"BioCryst director Amy E. McKee sells 11,180 shares worth $100,284.6","url":"https://stock-news.laohu8.com/highlight/detail?id=2636586103","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636586103?lang=en_us&edition=fundamental","pubTime":"2026-05-20 04:08","pubTimestamp":1779221303,"startTime":"0","endTime":"0","summary":"BioCryst Pharmaceuticals: Director Amy E. McKee sold 11,180 common shares on May 18, 2026.The shares were sold at a weighted average price of USD 8.97.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCryst Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 19, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL3Zpgz4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BioCryst director Amy E. McKee sells 11,180 shares worth $100,284.6","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4547","BCRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635037292","title":"BioCryst Chief Legal Officer Alane P. Barnes sells 62,500 shares for $596,250","url":"https://stock-news.laohu8.com/highlight/detail?id=2635037292","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635037292?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:14","pubTimestamp":1778876073,"startTime":"0","endTime":"0","summary":"BioCryst Pharmaceuticals Chief Legal Officer Alane P. Barnes exercised employee stock options for 62,500 shares at USD 5.04 on May 13, 2026.Barnes sold 62,500 shares at USD 9.54 in same session.Directly owned stake fell to 400,703 shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCryst Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL8xfxTZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BioCryst Chief Legal Officer Alane P. Barnes sells 62,500 shares for $596,250","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCRX","BK4547","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633127741","title":"These Analysts Revise Their Forecasts On BioCryst Pharma After Q1 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2633127741","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633127741?lang=en_us&edition=fundamental","pubTime":"2026-05-08 01:46","pubTimestamp":1778175972,"startTime":"0","endTime":"0","summary":"BioCryst Pharma (NASDAQ:BCRX) reported strong Q1 earnings, reaffirmed FY2026 sales guidance, and received positive price target changes from analysts.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/05/52381286/these-analysts-revise-their-forecasts-on-biocryst-pharma-after-q1-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4547","BK4139","BCRX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":111,"code":"91000000","status":"200"}]}}